Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

2 results about "Tilmicosin" patented technology

Tilmicosin is a macrolide antibiotic. It is used in veterinary medicine for the treatment of bovine respiratory disease and enzootic pneumonia caused by Mannheimia (Pasteurella) haemolytica in sheep. In humans, Tilmicosin causes fatal cardiotoxic effects at amounts greater than 1 milliliter when injected, something most commonly seen in veterinary personnel and farmers.

Veterinary compound tilmicosin injection and preparation method thereof

The invention discloses a veterinary compound tilmicosin injection and a preparation method thereof. 100ml of the veterinary compound tilmicosin injection comprises 15-30g of tilmicosin, 4-10g of florfenicol, 0.5-1.0g of an anti-oxidant, 3.3-8.0g of a cosolvent and the balance injection water. The veterinary compound tilmicosin injection having stable performances is prepared from tilmicosin and florfenicol as main raw materials and the anti-oxidant and the cosolvent as auxiliary materials. After intramuscular injection, the veterinary compound tilmicosin injection can be easily absorbed by animals and even completely absorbed, improves bioavailability, has long drug active ingredient action time, can be used for clinical treatment on livestock and poultry respiratory tract system disease caused by a plurality of pathogenic bacteria, has good curative effects and is convenient for use. The preparation method of the veterinary compound tilmicosin injection has simple processes, is convenient for operation and is suitable for large-scale industrial production.
Owner:ZHENGZHOU HOUYI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products